ASTA Follows Up with FDA on Saffron Holds and Rejections
ASTA met with U.S. Food and Drug Administration (FDA) officials regarding the increased inspection and detention of saffron shipments for economically motivated adulteration.
Membership Required
A valid ASTA membership is required to access this page. Please use the form below to log in with your ASTA member account.
Log in
Not a member yet? Click here to learn about joining ASTA today.
Related Resources
2025 Annual Report Now Available
News & Updates
Industry News
3/11/2025
Check out ASTA's 2025 Annual Report which provides an annual summary of ASTA's work and progress, including financial statements as well as governance information.
ASTA Provides Feedback to GAO on FDA Implementation of FSMA
News & Updates
Industry News
10/15/2024
This is an article from the October 15, 2024, FYI ASTA newsletter.